or
forgot password

H-8577:Genetic Susceptibility to Bladder Cancer: A Molecular Epidemiology Approach


N/A
N/A
N/A
Open (Enrolling)
Both
Bladder Cancer, Healthy

Thank you

Trial Information

H-8577:Genetic Susceptibility to Bladder Cancer: A Molecular Epidemiology Approach


Inclusion Criteria:



- Subject has a histologically confirmed diagnosis of superficial or muscle-invasive
bladder cancer

- Subject is a Texas resident.

- Subject can understand English or a qualified translator is available for the
interview.

- Subjects of any age, gender, or ethnicity are eligible to participate in the study.

- Subject consents to participate in the study.

Exclusion Criteria:

- Subject has had prior treatment with systemic chemotherapy or radiotherapy in the
past 6 months.

- Subject has been diagnosed with superficial or muscle-invasive bladder cancer more
than twelve months ago.

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

To assess both cohorts, two mutagen sensitivity susceptibility assays that quantifies the number of lymphocytic chromatid breaks induced by in vitro exposure to bleomycin and the number of breaks induced by in vitro exposure to a tobacco carcinogen.

Outcome Time Frame:

After last subject has completed the study

Safety Issue:

No

Principal Investigator

Seth P. Lerner, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Baylor College of Medicine

Authority:

United States: Institutional Review Board

Study ID:

H-8577

NCT ID:

NCT00848289

Start Date:

July 2008

Completion Date:

January 2014

Related Keywords:

  • Bladder Cancer
  • Healthy
  • Bladder cancer
  • Genetic susceptibility
  • Increased Risk
  • Urinary Bladder Neoplasms
  • Disease Susceptibility

Name

Location
Baylor College of Medicine Houston, Texas  77030
M.D. Anderson Cancer Center Houston, Texas  77030